News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Crucell N.V. (CRXL) Announces Marketing and Distribution Deal with Sanquin Blood Supply Foundation


11/12/2007 10:08:39 AM

LEIDEN, NETHERLANDS--(Marketwire - November 12, 2007) - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced the start of a marketing and distribution agreement with Sanquin, the Dutch Blood Supply Foundation.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES